Sign in to view content

Combination Therapy With Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

Jeffrey S. Heier, MD

Video
Published 2018

Related

Pyron Award, “Treating AMD: Back to the Future”, Joan W. Miller, MD
Joan W. Miller, MD
Annual Meeting Talks
2018
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Integrin Antagonism for DME
Hugo Quiroz-Mercado, MD
Updates from the Field
2019

Category: Diabetic Retinopathy

See more